Iradimed Corp. (IRMD) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
IRADIMED CORPORATION Announces First Quarter 2015 Financial Results
April 30, 2015 7:01 AM EDTReports first quarter 2015 non-GAAP diluted EPS of $0.14 Revenue grows 96.5% compared to the same quarter last year Increases full year 2015 revenue and non-GAAP earnings guidance Announces second quarter financial guidance
WINTER SPRINGS, Fla., April 30, 2015 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (Nasdaq: IRMD), the only known provider of non-magnetic intravenous (IV) infusion pump systems that are designed to be safe for use during magnetic resonance imaging (MRI) procedures, today announced financial results for the three months ended March 31, 2015.
For the first quarter ended March 31, 2015, the Company reported revenue of $7.0... More
